15.0 REFERENCES 
1 . Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in 
colonic carcinoma: an analysis of 1541 necropsies. J. Pathol. 1986;150:195-203. 
2. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of 
patients with Ever metastases from colorectal cancer. Clin. Oncol. 1976;2:285-288. 
3 . Cook G, Moose B. Hepatocellular carcinoma: one of the world's most common 
malignances. Am. J. Med. 1985;235:705-8. 
4 . Venook AP. Treatment of hepatocellular carcinoma: too many options? J. Clin. 
Oncol. 1994;12:1323-34. 
5. Breedis C, Young G. Blood supply of neoplasms of the liver. Am. J. Pathol. 
1954;30:969-985. 
6 . Kemeny N, Cohen A, Bertino JR, et al. Continuous intrahepatic infusion of 
floxuridine and leucovorin through an implantable pump for the treatment of hepatic 
hetastases from colorectal carcinoma. Caricer 1990;65:2446-50. 
7 . Stagg RJ, Venook AP, Chase JL, et al. Alternating hepatic intra-arterial floxuridine 
and fluorouracil: a less toxic regimen for treatment of liver metastases from 
colorectal cancer. J. Nad. Cancer Inst. 1991;83:423-428. 
8 . Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Inducuon of apoptosis by 
wild-type p53 in a human colon tumor-derived cell line. Proc. Nad. Acad. Sci. 
USA 1992;89:4495-9. 
9 . Wills KN, Maneval DC, Menzel P, et al. Development and characterization of 
recombinant adenoviruses encoding p53 for gene therapy of cancer. Human Gene 
Therapy 1994; tin press. 
Recombinant DNA Research, Volume 20 
[691] 
